Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors

SIMPLE SUMMARY: Hepatitis is a relatively frequent immune-related adverse event in patients with hepatocellular carcinoma receiving immunotherapy, but risk factors and clinical course are unclear. Herein, we show that the development of high-grade hepatitis is associated with increased baseline ALT...

Descripción completa

Detalles Bibliográficos
Autores principales: Personeni, Nicola, Pressiani, Tiziana, D’Alessio, Antonio, Prete, Maria Giuseppina, Bozzarelli, Silvia, Terracciano, Luigi, Dal Buono, Arianna, Capogreco, Antonio, Aghemo, Alessio, Lleo, Ana, Lutman, Romano Fabio, Roncalli, Massimo, Giordano, Laura, Santoro, Armando, Di Tommaso, Luca, Rimassa, Lorenza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616285/
https://www.ncbi.nlm.nih.gov/pubmed/34830823
http://dx.doi.org/10.3390/cancers13225665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616285/
https://www.ncbi.nlm.nih.gov/pubmed/34830823
http://dx.doi.org/10.3390/cancers13225665

Ejemplares similares